MLchartDataset catalogue

Plenaxis

Term · Oncology and biomedicine · MLC-T-ONC-006740

A drug used to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available. It belongs to the family of drugs called gonadotropin-releasing hormone (GnRH) antagonists. Also called abarelix.

Table 1. Record
IdentifierMLC-T-ONC-006740
FieldOncology and biomedicine
Synonymsabarelix
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-006740",
  "term": "Plenaxis",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available. It belongs to the family of drugs called gonadotropin-releasing hormone (GnRH) antagonists. Also called abarelix.",
  "synonyms": [
    "abarelix"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/plenaxis/"
}

Record 13,340 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.